Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06ODM
|
||||
Former ID |
DCL000303
|
||||
Drug Name |
Talsaclidine fumarate
|
||||
Synonyms |
Wal 2014 FU; Talsaclidine fumarate (USAN); (E)-but-2-enedioic acid; 1-Azabicyclo(2.2.2)octane, 3-(2-propynyloxy)-, (R)-, (E)-2-butenedioate (1:1); 3-(2-Propynyloxy)-1-azabicyclo(2.2.2)octane 2-butenedioate; 3-prop-2-ynoxy-1-azabicyclo[2.2.2]octane
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Alzheimer disease [ICD9: 331; ICD10:G30] | Discontinued in Phase 2 | [545043] | ||
Company |
Boehringer
|
||||
Structure |
Download2D MOL |
||||
Formula |
C14H19NO5
|
||||
Canonical SMILES |
C#CCOC1CN2CCC1CC2.C(=CC(=O)O)C(=O)O
|
||||
InChI |
1S/C10H15NO.C4H4O4/c1-2-7-12-10-8-11-5-3-9(10)4-6-11;5-3(6)1-2-4(7)8/h1,9-10H,3-8H2;1-2H,(H,5,6)(H,7,8)/b;2-1+
|
||||
InChIKey |
SBCXBWBXWKVIFK-WLHGVMLRSA-N
|
||||
CAS Number |
CAS 147025-54-5
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Muscarinic acetylcholine receptor M1 | Target Info | Agonist | [535511], [537030] | |
References | |||||
Ref 535511 | Memory-related task performance by aged rhesus monkeys administered the muscarinic M(1)-preferring agonist, talsaclidine. Psychopharmacology (Berl). 2002 Jul;162(3):292-300. Epub 2002 May 29. | ||||
Ref 537030 | Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists. Eur J Pharmacol. 2009 Mar 1;605(1-3):53-6. Epub 2009 Jan 11. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.